Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

Shanghai-based brain-computer interface (BCI) company StairMed, which claims to outperform Elon Musk’s Neuralink in certain ...

By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...

and Lilly Asia Ventures, a spin-off of American pharmaceutical giant Eli Lilly. StairMed called it the largest fundraising round for a Chinese implantable BCI company, according to a post on ...

Foreign investments in Flanders created 5,000 new jobs in 2024, with the United States accounting for 21.6% of total projects, including a strong presence in the pharmaceutical and biotech sectors.

As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, new survey results from 9amHealth reveal that access to these medications has become a ...

Now, AH and Eli Lilly are rewriting the playbook with a ... Corporations prioritize consistent and growing cash flow and avoid high risk ventures. In contrast, VCs bet on future valuations and ...

AdvanCell announced the successful completion of an oversubscribed $112 million (US) Series C financing, making it the only ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

Kim Hak-kyun, CEO of Quantum Ventures Korea, was elected as the final candidate for the presidency of the Korea Venture Capital Association. Kim is the only candidate born in the 1970s among those ...

AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...